4.6 Review

Decorin treatment of spinal cord injury

Journal

NEURAL REGENERATION RESEARCH
Volume 9, Issue 18, Pages 1653-1656

Publisher

SHENYANG EDITORIAL DEPT NEURAL REGENERATION RES
DOI: 10.4103/1673-5374.141797

Keywords

spinal cord injury; Decorin; transforming growth factor-beta; scarring; chondroitin sulphate proteoglycan; matrix metalloproteases

Funding

  1. Wellcome Trust [092539/Z/10/Z]
  2. International Spinal Research Trust [STR103]
  3. National Institute for Health research (NIHR) Surgical Reconstruction and Microbiology Research Centre
  4. International Spinal Research Trust [STR103] Funding Source: researchfish
  5. Wellcome Trust [092539/Z/10/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

The scarring response after a penetrant central nervous system injury results from the interaction between invading leptominingeal/pericyte-derived fibroblasts and endogenous reactive astrocytes about the wound margin. Extracellular matrix and scar-derived axon growth inhibitory molecules fill the lesion site providing both a physical and chemical barrier to regenerating axons. Decorin, a small leucine-rich chondroitin-dermatan sulphate proteoglycan expressed by neurons and astrocytes in the central nervous system, is both anti-fibrotic and anti-inflammatory and attenuates the formation and partial dissolution of established and chronic scars. Here, we discuss the potential of using Decorin to antagonise scarring in the central nervous system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available